Surgical Science Sweden マネジメント
マネジメント 基準チェック /24
現在、CEO に関する十分な情報がありません。
主要情報
Tom Englund
最高経営責任者
n/a
報酬総額
| CEO給与比率 | n/a |
| CEO在任期間 | less than a year |
| CEOの所有権 | n/a |
| 経営陣の平均在職期間 | 3.8yrs |
| 取締役会の平均在任期間 | 3.5yrs |
経営陣の近況
Recent updates
The Price Is Right For Surgical Science Sweden AB (publ) (STO:SUS)
Nov 12
Surgical Science Sweden AB (publ) Just Missed EPS By 22%: Here's What Analysts Think Will Happen Next
Aug 25Earnings Beat: Surgical Science Sweden AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Apr 21Here's Why Surgical Science Sweden (STO:SUS) Has Caught The Eye Of Investors
Apr 16Surgical Science Sweden AB (publ)'s (STO:SUS) Share Price Is Still Matching Investor Opinion Despite 25% Slump
Mar 17Results: Surgical Science Sweden AB (publ) Beat Earnings Expectations And Analysts Now Have New Forecasts
Feb 24Is There Now An Opportunity In Surgical Science Sweden AB (publ) (STO:SUS)?
Nov 29Should You Be Adding Surgical Science Sweden (STO:SUS) To Your Watchlist Today?
Oct 07Is Surgical Science Sweden AB (publ) (STO:SUS) Trading At A 39% Discount?
Aug 17With EPS Growth And More, Surgical Science Sweden (STO:SUS) Makes An Interesting Case
Jun 20A Look At The Fair Value Of Surgical Science Sweden AB (publ) (STO:SUS)
May 17Surgical Science Sweden AB (publ) (STO:SUS) Shares Could Be 49% Below Their Intrinsic Value Estimate
Dec 27Is Now The Time To Put Surgical Science Sweden (STO:SUS) On Your Watchlist?
Dec 06Is Now The Time To Look At Buying Surgical Science Sweden AB (publ) (STO:SUS)?
Sep 08We Ran A Stock Scan For Earnings Growth And Surgical Science Sweden (STO:SUS) Passed With Ease
Aug 23Surgical Science Sweden AB (publ) (STO:SUS) Shares Slammed 33% But Getting In Cheap Might Be Difficult Regardless
May 26Here's Why We Think Surgical Science Sweden (STO:SUS) Is Well Worth Watching
Apr 29An Intrinsic Calculation For Surgical Science Sweden AB (publ) (STO:SUS) Suggests It's 44% Undervalued
Feb 20Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?
Jan 11Does Surgical Science Sweden (STO:SUS) Deserve A Spot On Your Watchlist?
Dec 15Calculating The Intrinsic Value Of Surgical Science Sweden AB (publ) (STO:SUS)
Sep 16Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?
Jul 05Calculating The Fair Value Of Surgical Science Sweden AB (publ) (STO:SUS)
Jun 08Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?
Mar 23Calculating The Intrinsic Value Of Surgical Science Sweden AB (publ) (STO:SUS)
Mar 02Is Surgical Science Sweden AB (publ)'s (STO:SUS) Shareholder Ownership Skewed Towards Insiders?
Feb 09
Surgical Science Sweden AB (publ)'s (STO:SUS) Stock Is Going Strong: Have Financials A Role To Play?
Jan 01What Does Surgical Science Sweden AB (publ)'s (STO:SUS) Share Price Indicate?
Dec 14Does Surgical Science Sweden (STO:SUS) Deserve A Spot On Your Watchlist?
Nov 26CEO（最高経営責任者
Tom Englund (48 yo)
less than a year
在職期間
Mr. Tom Englund is Chief Executive Officer of Surgical Science Sweden AB (publ) from October 1, 2024. Mr. Englund served as Division Chief Executive Officer of Tobii Pro and Deputy Chief Executive Officer...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Advisor & Director | less than a year | SEK 5.83m | 0.67% SEK 50.1m | |
| Chief Executive Officer | less than a year | データなし | データなし | |
| Co-Founder & CTO | 5.8yrs | データなし | 0.059% SEK 4.4m | |
| Chief Financial Officer | 6.8yrs | データなし | 0.047% SEK 3.5m | |
| Chief Operating Officer | 3.8yrs | データなし | 0.036% SEK 2.7m | |
| Head of Global Sales | 3.8yrs | データなし | データなし | |
| Executive Vice President of Products & Marketing | 3yrs | データなし | 0.036% SEK 2.7m | |
| Head of Development | 5yrs | データなし | データなし | |
| Chief Innovation Officer | 3.8yrs | データなし | データなし | |
| President of Research & Development | 2.8yrs | データなし | 0.042% SEK 3.2m | |
| Executive Vice President of International Sales & Educational Products | no data | データなし | 0.010% SEK 753.2k | |
| Executive Vice President of Industry & OEM | 2.5yrs | データなし | データなし |
3.8yrs
平均在職期間
54.5yo
平均年齢
経験豊富な経営陣: SUSの経営陣は 経験豊富 であると考えられます ( 3.8年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Advisor & Director | less than a year | SEK 5.83m | 0.67% SEK 50.1m | |
| Chairman of the Board | 19.8yrs | データなし | 11.74% SEK 876.7m | |
| Director | 19.8yrs | データなし | 13.99% SEK 1.0b | |
| Independent Director | 7.8yrs | データなし | 0.0020% SEK 146.3k | |
| Independent Director | 1.5yrs | データなし | 0.00069% SEK 51.5k | |
| Independent Director | 3.5yrs | データなし | 0.0026% SEK 190.4k | |
| Independent Director | 3.5yrs | データなし | 0.0020% SEK 146.3k |
3.5yrs
平均在職期間
52yo
平均年齢
経験豊富なボード: SUSの 取締役会 は 経験豊富 であると考えられます ( 3.5年の平均在任期間)。